about
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to s...
Read More
21.89
0.49
(2.29%)
1.9M
XNAS Volume
XNAS 21 Sep, 2026 5:30 PM (EDT)
Board Meeting
The next board meeting for Vor Biopharma Inc is on 23 Sep 2026 for the purpose of Stifel’s 2026 Virtual Immunology and Inflammation Forum
See details
Not Eligible
Expensive Valuation
Technically Neutral
Vor Biopharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..